Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Long-Term Deferred Tax (2017 - 2018)

Historic Long-Term Deferred Tax for BioRestorative Therapies (BRTX) over the last 2 years, with Q4 2018 value amounting to $8.2 million.

  • BioRestorative Therapies' Long-Term Deferred Tax rose 5077.23% to $8.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $8.2 million, marking a year-over-year increase of 5077.23%. This contributed to the annual value of $8.2 million for FY2018, which is 5077.23% up from last year.
  • Latest data reveals that BioRestorative Therapies reported Long-Term Deferred Tax of $8.2 million as of Q4 2018, which was up 5077.23% from $5.4 million recorded in Q4 2017.
  • In the past 5 years, BioRestorative Therapies' Long-Term Deferred Tax registered a high of $8.2 million during Q4 2018, and its lowest value of $5.4 million during Q4 2017.